Todd has over 30 years of accounting, finance, tax, private equity, and venture capital experience.  Prior to joining Portal, Todd served as CFO for a private equity group where he has also supported multiple portfolio companies in the CFO role as well as Senior Tax Analyst for a public company owned by the group.  In addition, Todd managed the family office for the principal of the private equity group where he was responsible for investment analysis and due diligence, risk management, cash management, tax compliance and planning, and estate planning.  Prior to that, Todd spent four years with the accounting firm of Price Waterhouse Coopers LLP representing the firm’s audit and tax practice.

Jeremy joins Portal Innovations as an Analyst on the Venture Team, identifying early differentiated technologies in the life science field. He also works closely on the creation and development of Portal Stargaze™️, a ML-driven analytics tool for tracking and identifying industry trends and researchers of interest. Jeremy graduated from Vanderbilt University in May of 2023 with a BE degree in Biomedical Engineering but has been working with Portal since 2021 as both a summer intern and remote employee. His past work has centered around venture assistance, portfolio company support, and Stargaze™️ development. At Vanderbilt, he had experience in both a wet lab doing cardiopulmonary research and computational research developing bioinformatic tools for single cell RNA sequencing.

Sylwia is an Accounting Manager in the Finance Operations Department at Portal. Her extensive professional experience encompasses overseeing accounting operations, including month-end close, accounts payable and accounts receivable as well as working with external and internal business partners.  She holds a Bachelor’s degree in Accounting and Finance as well as a Master’s degree in Accounting all from Roosevelt University.

Gianina is a Biotech entrepreneur passionate about bringing scientific discoveries to patients. She has experience in developing biotech start-ups from the ground up, ranging from strategy to operations and project management, as well as direct involvement in seeking non-dilutive and private funding from institutional and strategic investors. The most recent startup she helped build was Pyxis Oncology. As a Technology Venture Fellow at the Polsky Center at The University of Chicago she worked closely with Pyxis’ founding team to develop the strategic and financial materials to support Pyxis’ formation and $22M Series A. As Pyxis’ first employee, she worked as project and alliance manager, and in business development. She also supported the $150M Series B, several partnerships, and the IPO in October 2021. Gianina obtained her Masters’ degree in Bioscience Enterprise (MBE) at The University of Cambridge and a B.S. in Molecular Biotechnology Engineering from The University of Chile.

Dr. Schultz is a scientist by training. He assesses new investment opportunities and supports companies within the Portal/Fulton Labs ecosystem. Before joining Portal, he was a life sciences consultant where he advised therapeutics, diagnostics, and medical device companies on indication prioritization, competitive landscape analysis, and revenue forecasting. He completed his PhD at Harvard Medical School where he researched mechanisms that underlie the aging process, with a focus on biomarkers, inflammation, and metabolism.

As a Senior Director of Financial Operations & Controller for Portal Innovations, Ula oversees financial reporting and daily financial operations for the company. Ula has spent most of her career in healthcare finance, most recently as a Controller at Swedish Hospital part of NorthShore, where she was responsible for managing financial operations and overseeing financial reporting, accounting, accounts payable and treasury for several corporations. Ula’s strong business acumen aided her in leading several strategic initiatives that resulted in improvement of efficiency, reporting and daily financial operations. She brings a fresh perspective to building and leading finance teams, focusing on collaboration, empowerment and business growth.

Steve is a “startup midwife” who has spent the last decade helping inventors turn their discoveries into businesses, whether in a startup, a university, or even a refugee camp. He most recently led the George Shultz Innovation Fund at UChicago, where he nucleated and invested in University spinouts. Prior to UChicago he was an Associate for Ocean Tomo’s Innovation Management practice, where he advised companies on how to acquire, develop, and commercialize technologies.